Safety Study to Evaluate the Effects of Mild and Moderate Renal Impairment on the Pharmacokinetics of ABT-335 and Rosuvastatin When Administered Concomitantly
Clinical trial NCT00585143 · COMPLETED
Trial details
- NCT number
- NCT00585143
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2008-10-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.